Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 4043516, 8 pages
https://doi.org/10.1155/2017/4043516
Review Article

miRNAs: Important Targets for Oral Cancer Pain Research

1Programa de Pós-Graduação em Biomedicina Translacional, Universidade do Grande Rio (Unigranrio), Duque de Caxias, RJ, Brazil
2Programa de Pós-Graduação em Odontologia Clínica e Experimental, Universidade do Grande Rio (Unigranrio), Duque de Caxias, RJ, Brazil
3Universidade Federal do Rio de Janeiro (UFRJ), Campus Macaé, Macaé, RJ, Brazil
4Sociedade Brasileira para o Estudo da Dor (SBED), São Paulo, SP, Brazil
5Programa de Pós-Graduação em Radiologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil
6Headache & Orofacial Pain Effort (HOPE), Department of Biologic and Materials Sciences & Michigan Center for Oral Health Research (MCOHR), School of Dentistry, University of Michigan, Ann Arbor, MI, USA
7Instituto de Ciências Biomédicas (ICB), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil
8Instituto Estadual do Cérebro Paulo Niemeyer (IECPN), Rio de Janeiro, RJ, Brazil

Correspondence should be addressed to Marcos F. DosSantos; moc.liamg@hfmsotnas

Received 28 February 2017; Revised 28 August 2017; Accepted 14 September 2017; Published 30 October 2017

Academic Editor: Ming D. Li

Copyright © 2017 Cláudia Maria Pereira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Tataru, V. Mak, R. Simo, E. A. Davies, and J. E. Gallagher, “Trends in the epidemiology of head and neck cancer in London,” Clinical Otolaryngology, vol. 42, no. 1, pp. 104–114, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Marur and A. A. Forastiere, “Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment,” Mayo Clinic Proceedings, vol. 91, no. 3, pp. 386–396, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Fedele, “Diagnostic aids in the screening of oral cancer.,” Head & neck oncology, vol. 1, p. 5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. L. Gillison, “Current topics in the epidemiology of oral cavity and oropharyngeal cancers,” Head & Neck, vol. 29, no. 8, pp. 779–792, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. B. K. Edwards, M. L. Brown, P. A. Wingo et al., “Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment,” Journal of the National Cancer Institute, vol. 97, no. 19, pp. 1407–1427, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. W. J. Blot, J. K. McLaughlin, D. M. Winn et al., “Smoking and drinking in relation to oral and pharyngeal cancer,” Cancer Res, vol. 48, no. 11, pp. 3282–3287, 1988. View at Google Scholar
  7. A. K. Chaturvedi, E. A. Engels, W. F. Anderson, and M. L. Gillison, “Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States,” Journal of Clinical Oncology, vol. 26, no. 4, pp. 612–619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. L. Gillison, W. M. Koch, R. B. Capone et al., “Evidence for a causal association between human papillomavirus and a subset of head and neck cancers,” Journal of the National Cancer Institute, vol. 92, no. 9, pp. 709–720, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Baumann and M. Krause, “Targeting the epidermal growth factor receptor in radiotherapy: Radiobiological mechanisms, preclinical and clinical results,” Radiotherapy & Oncology, vol. 72, no. 3, pp. 257–266, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Keren, Z. Shoude, Z. Lu, and Y. Beibei, “Role of EGFR as a prognostic factor for survival in head and neck cancer: A meta-analysis,” Tumor Biology, vol. 35, no. 3, pp. 2285–2295, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. M. Pereira, C. C. Gomes, J. D. F. C. Silva, M. B. Rodriguez, A. A. Barbosa, and R. S. Gomez, “Evaluation of MAGE A1 in oral squamous cell carcinoma,” Oncology Reports, vol. 27, no. 6, pp. 1843–1848, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. F. T. Zamunér, B. T. R. Karia, C. Z. De Oliveira, C. R. Dos Santos, A. L. Carvalho, and A. L. Vettore, “A comprehensive expression analysis of cancer testis antigens in head and neck squamous cell carcinoma revels MAGEA3/6 as a marker for recurrence,” Molecular Cancer Therapeutics, vol. 14, no. 3, pp. 828–834, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Nagadia, P. Pandit, W. B. Coman, J. Cooper-White, and C. Punyadeera, “MiRNAs in head and neck cancer revisited,” Cellular Oncology, vol. 36, no. 1, pp. 1–7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Summerer, M. Niyazi, K. Unger et al., “Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients,” Journal of Radiation Oncology, vol. 8, no. 1, article 296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Wang, E. M. Sturgis, X. Chen, H. Zheng, Q. Wei, and G. Li, “Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx,” Oncotarget , vol. 7, no. 18, pp. 26444–26453, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Sato, Y. Yamazaki, A. Satoh et al., “Pain may predict poor prognosis in patients with oral squamous cell carcinoma,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol. 111, no. 5, pp. 587–592, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Werkmeister, B. Brandt, and U. Joos, “The erbB oncogenes as prognostic markers in oral squamous cell carcinomas,” The American Journal of Surgery, vol. 172, no. 6, pp. 681–683, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Myoung, M. J. Kim, J. H. Lee, Y. J. Ok, J. Y. Paeng, and P. Y. Yun, “Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients,” Int J Oral Maxillofac Surg, vol. 35, no. 11, pp. 1005–1010, 2006. View at Google Scholar
  19. L. S. Monteiro, M. Diniz-Freitas, T. Garcia-Caballero, S. Warnakulasuriya, J. Forteza, and M. Fraga, “Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma,” Journal of Oral Pathology & Medicine, vol. 41, no. 7, pp. 559–567, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Min, C. Zhu, S. Peng, S. Rajthala, D. E. Costea, and D. Sapkota, “MicroRNAs as important players and biomarkers in oral carcinogenesis,” BioMed Research International, vol. 2015, Article ID 186904, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Rivera, A. K. Oliveira, R. A. P. Costa, T. De Rossi, and A. F. Paes Leme, “Prognostic biomarkers in oral squamous cell carcinoma: a systematic review,” Oral Oncology, vol. 72, pp. 38–47, 2017. View at Publisher · View at Google Scholar
  22. J. Bagan, G. Sarrion, and Y. Jimenez, “Oral cancer: clinical features,” Oral Oncology, vol. 46, no. 6, pp. 414–417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. H.-B. Santos, T.-K. dos Santos, A.-R. Paz et al., “Clinical findings and risk factors to oral squamous cell carcinoma in young patients: A 12-year retrospective analysis,” Medicina Oral Patología Oral y Cirugía Bucal, vol. 21, no. 2, pp. e151–e156, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. N. G. Nikitakis, E. Sarlani, A. Kolokythas et al., “Frequency of pain and correlation with clinical and histologic parameters in T1 squamous cell carcinoma of the tongue: a retrospective pilot study.,” Journal of oral & facial pain and headache, vol. 28, no. 1, pp. 46–51, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. B. L. Schmidt, “The Neurobiology of Cancer Pain,” Journal of Oral and Maxillofacial Surgery, vol. 73, no. 12, pp. S132–S135, 2015. View at Publisher · View at Google Scholar
  26. K. K. Bali, D. Selvaraj, V. P. Satagopam, J. Lu, R. Schneider, and R. Kuner, “Genome-wide identification and functional analyses of microRNA signatures associated with cancer pain,” EMBO Molecular Medicine, vol. 5, no. 11, pp. 1740–1758, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Descalzi, D. Ikegami, T. Ushijima, E. J. Nestler, V. Zachariou, and M. Narita, “Epigenetic mechanisms of chronic pain,” Trends in Neurosciences, vol. 38, no. 4, pp. 237–246, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. S. T. Connelly and B. L. Schmidt, “Evaluation of pain in patients with oral squamous cell carcinoma,” The Journal of Pain, vol. 5, no. 9, pp. 505–510, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. C.-F. Yeh, W.-Y. Li, P.-Y. Chu et al., “Pretreatment pain predicts perineural invasion in oral squamous cell carcinoma: A prospective study,” Oral Oncology, vol. 61, pp. 115–119, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Buchheit, T. Van de Ven, and A. Shaw, “Epigenetics and the Transition from Acute to Chronic Pain,” Pain Medicine, vol. 13, no. 11, pp. 1474–1490, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. V. Iorio and C. M. Croce, “MicroRNAs in cancer: small molecules with a huge impact,” Journal of Clinical Oncology, vol. 27, no. 34, pp. 5848–5856, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. A. L. Gartel and E. S. Kandel, “RNA interference in cancer,” Biomolecular Engineering, vol. 23, no. 1, pp. 17–34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Zhang, Y.-Q. Cai, F. Zou, B. Bie, and Z. Z. Pan, “Epigenetic suppression of GAD65 expression mediates persistent pain,” Nature Medicine, vol. 17, no. 11, pp. 1448–1455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Wang, S. Zhang, J. Weber, D. Baxter, and D. J. Galas, “Export of microRNAs and microRNA-protective protein by mammalian cells,” Nucleic Acids Research, vol. 38, no. 20, pp. 7248–7259, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Niederberger, K. Kynast, J. Lötsch, and G. Geisslinger, “MicroRNAs as new players in the pain game,” PAIN, vol. 152, no. 7, pp. 1455–1458, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Bai, R. Ambalavanar, D. Wei, and D. Dessem, “Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain,” Molecular Pain, vol. 3, article no. 15, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Tajerian, S. Alvarado, M. Millecamps et al., “Peripheral nerve injury is associated with chronic, reversible changes in global DNA methylation in the mouse prefrontal cortex,” PLoS ONE, vol. 8, no. 1, Article ID e55259, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Imai, M. Saeki, M. Yanase et al., “Change in microRNAS associated with neuronal adaptive responses in the nucleus accumbens under neuropathic pain,” The Journal of Neuroscience, vol. 31, no. 43, pp. 15294–15299, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Kress, A. Hüttenhofer, M. Landry et al., “microRNAs in nociceptive circuits as predictors of future clinical applications,” Frontiers in Molecular Neuroscience, vol. 6, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. I. A. Orlova, G. M. Alexander, R. A. Qureshi et al., “MicroRNA modulation in complex regional pain syndrome,” Journal of Translational Medicine, vol. 9, no. 1, article no. 195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. J. L. Bjersing, C. Lundborg, M. I. Bokarewa, and K. Mannerkorpi, “Profile of Cerebrospinal microRNAs in Fibromyalgia,” PLoS ONE, vol. 8, no. 10, Article ID e78762, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. Q. Zhou, W. W. Souba, C. M. Croce, and G. N. Verne, “MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome,” Gut, vol. 59, no. 6, pp. 775–784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Beyer, A. Zampetaki, N. Lin et al., “Signature of circulating microRNAs in osteoarthritis,” Annals of the Rheumatic Diseases, vol. 74, no. 3, pp. e18–e18, 2015. View at Publisher · View at Google Scholar
  45. Q. Zhou, L. Yang, S. Larson et al., “Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1,” Gut, vol. 65, no. 5, pp. 797–805, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. H. H. Andersen, M. Duroux, and P. Gazerani, “Serum MicroRNA Signatures in Migraineurs During Attacks and in Pain-Free Periods,” Molecular Neurobiology, vol. 53, no. 3, pp. 1494–1500, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. M. F. DosSantos, R. C. Holanda-Afonso, R. L. Lima, A. F. DaSilva, and V. Moura-Neto, “The role of the blood–brain barrier in the development and treatment of migraine and other pain disorders,” Frontiers in Cellular Neuroscience, vol. 8, article no. 302, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. K. L. Burgos, A. Javaherian, R. Bomprezzi et al., “Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing,” RNA, vol. 19, no. 5, pp. 712–722, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Sakai and H. Suzuki, “Nerve injury-induced upregulation of miR-21 in the primary sensory neurons contributes to neuropathic pain in rats,” Biochemical and Biophysical Research Communications, vol. 435, no. 2, pp. 176–181, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. C. I. Svensson, “Interleukin-6: A local pain trigger?” Arthritis Research & Therapy, vol. 12, no. 5, article no. 145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Gangadharan and R. Kuner, “Pain hypersensitivity mechanisms at a glance,” Disease Models & Mechanisms, vol. 6, no. 4, pp. 889–895, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. V. Benes, P. Collier, C. Kordes et al., “Identification of cytokine-induced modulation of microRNA expression and secretion as measured by a novel microRNA specific qPCR assay,” Scientific Reports, vol. 5, Article ID 11590, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Grace and B. Hall, “Comparison of flow cytometric data obtained using fresh and paraffin-embedded lymphoid tissue,” Anal Quant Cytol Histol, vol. 11, no. 1, pp. 67–71, 1989. View at Google Scholar
  54. J.-S. Kim, S.-K. Yu, M.-H. Lee et al., “MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells,” Molecules and Cells, vol. 35, no. 1, pp. 17–24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. A. J. Asirvatham, W. J. Magner, and T. B. Tomasi, “miRNA regulation of cytokine genes,” Cytokine, vol. 45, no. 2, pp. 58–69, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Arai, Y. Genda, M. Ishikawa, T. Shunsuke, T. Okabe, and A. Sakamoto, “The miRNA and mRNA Changes in Rat Hippocampi after Chronic Constriction Injury,” Pain Medicine, vol. 14, no. 5, pp. 720–729, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. K. K. Bali, M. Hackenberg, A. Lubin, R. Kuner, and M. Devor, “Sources of individual variability: MiRNAs that predispose to neuropathic pain identified using genome-wide sequencing,” Molecular Pain, vol. 10, no. 1, article no. 22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. J. N. Sengupta, S. Pochiraju, P. Kannampalli et al., “Erratum: MicroRNA-mediated GABAAα-1 receptor subunit down-regulation in adult spinal cord following neonatal cystitis-induced chronic visceral pain in rats (Pain (2012) 154:1 (59-70)),” PAIN, vol. 154, no. 3, p. 493, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Dong, P. Li, Y. Ni, J. Zhao, and Z. Liu, “Decreased microRNA-125a-3p contributes to upregulation of p38 MAPK in rat trigeminal ganglions with orofacial inflammatory pain,” PLoS ONE, vol. 9, no. 11, Article ID e111594, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Zhang, X. Fan, Y. Bai et al., “MiR-125b regulates procalcitonin production in monocytes by targeting Stat3,” Microbes and Infection, vol. 18, no. 2, pp. 102–108, 2016. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Dan, B. Jinjun, H. Zi-Chun et al., “Modulation of TNF-α mRNA stability by human antigen R and miR181s in sepsis-induced immunoparalysis,” EMBO Molecular Medicine, vol. 7, no. 2, pp. 140–157, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. L. Liu, Y. Wang, H. Fan et al., “MicroRNA-181a regulates local immune balance by inhibiting proliferation and immunosuppressive properties of mesenchymal stem cells,” Stem Cells, vol. 30, no. 8, pp. 1756–1770, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. X. He, Z. Liu, Y. Peng, and C. Yu, “MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-β pathway,” Biochemical and Biophysical Research Communications, vol. 469, no. 4, pp. 1041–1048, 2016. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Feng, M. Bai, N.-Z. Yu, X.-J. Wang, and Z. Liu, “MicroRNA-181b negatively regulates the proliferation of human epidermal keratinocytes in psoriasis through targeting TLR4,” Journal of Cellular and Molecular Medicine, vol. 21, no. 2, pp. 278–285, 2017. View at Publisher · View at Google Scholar · View at Scopus
  65. X. Jiang, C. Xu, F. Lei et al., “MiR-30a targets IL-1α and regulates islet functions as an inflammation buffer and response factor,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  66. A.-L. Gagez, I. Duroux-Richard, S. Leprêtre et al., “MIR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study,” Haematologica, vol. 102, no. 4, pp. 746–754, 2017. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Gong, J.-P. Zhang, B. Li et al., “MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R,” Oncogene, vol. 32, no. 25, pp. 3071–3079, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Gandla, S. K. Lomada, J. Lu, R. Kuner, and K. K. Bali, “miR-34c-5p functions as pronociceptive microRNA in cancer pain by targeting Cav2.3 containing calcium channels,” PAIN, vol. 158, no. 9, pp. 1765–1779, 2017. View at Publisher · View at Google Scholar
  69. B. J. Laird, D. C. McMillan, P. Fayers et al., “The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer,” The Oncologist, vol. 18, no. 9, pp. 1050–1055, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. D. Betel, M. Wilson, A. Gabow, D. S. Marks, and C. Sander, “The microRNA.org resource: targets and expression,” Nucleic Acids Research, vol. 36, no. 1, pp. D149–D153, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. X. Song, L. Cheng, T. Zhou et al., “Predicting miRNA-mediated gene silencing mode based on miRNA-target duplex features,” Computers in Biology and Medicine, vol. 42, no. 1, pp. 1–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. M. J. López-González, M. Landry, and A. Favereaux, “MicroRNA and chronic pain: From mechanisms to therapeutic potential,” Pharmacology & Therapeutics, 2017. View at Publisher · View at Google Scholar
  73. X. Sun, A. Sit, and M. W. Feinberg, “Role of miR-181 family in regulating vascular inflammation and immunity,” Trends in Cardiovascular Medicine, vol. 24, no. 3, pp. 105–112, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. J. C. Galicia, A. R. Naqvi, C.-C. Ko, S. Nares, and A. A. Khan, “MiRNA-181a regulates Toll-like receptor agonist-induced inflammatory response in human fibroblasts,” Genes & Immunity, vol. 15, no. 5, pp. 333–337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. Q. Wu, C. K. Hwang, H. Zheng et al., “MicroRNA 339 down-regulates μ-opioid μeceptor at the post-transcriptional level in response to opioid treatment,” The FASEB Journal, vol. 27, no. 2, pp. 522–535, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. N. Marie, B. Aguila, and S. Allouche, “Tracking the opioid receptors on the way of desensitization,” Cellular Signalling, vol. 18, no. 11, pp. 1815–1833, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. S. B. McMahon, Wall and Melzack's Textbook of Pain, Elsevier/Saunders. xxix, Philadelphia, PA, USA, 6th edition, 2013.
  78. M. J. Brownstein, “A brief history of opiates, opioid peptides, and opioid receptors.,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 90, no. 12, pp. 5391–5393, 1993. View at Publisher · View at Google Scholar
  79. C.-C. Yang, P.-S. Hung, P.-W. Wang et al., “miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma,” Journal of Oral Pathology & Medicine, vol. 40, no. 5, pp. 397–404, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. B. J. Henson, S. Bhattacharjee, D. M. O'Dee, E. Feingold, and S. M. Gollin, “Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy,” Genes, Chromosomes and Cancer, vol. 48, no. 7, pp. 569–582, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. A. M. Rose-Ped, L. A. Bellm, J. B. Epstein, A. Trotti, C. Gwede, and H. J. Fuchs, “Complications of radiation therapy for head and neck cancers: The patient's perspective,” Cancer Nursing, vol. 25, no. 6, pp. 461–469, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. D. J. Harris, “Cancer treatment-induced mucositis pain: Strategies for assessment and management,” Therapeutics and Clinical Risk Management, vol. 2, no. 3, pp. 251–258, 2006. View at Publisher · View at Google Scholar · View at Scopus